Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent Aug 3, 2021 Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure Jul 7, 2021 Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference Jul 6, 2021 Viveve Announces Issuance of New Device and Methods Patent in U.S. Jun 10, 2021 Viveve Announces Adjournment of Annual Meeting Jun 2, 2021 Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update May 13, 2021 Viveve Announces Adjournment of Annual Meeting May 11, 2021 Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update May 6, 2021 Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan Apr 1, 2021 Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update Mar 18, 2021 1 2 3 4 5 6 7 8 9 10 ...32
Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update May 6, 2021
